110 related articles for article (PubMed ID: 16195406)
1. Bone morphogenetic protein-4 inhibits corticotroph tumor cells: involvement in the retinoic acid inhibitory action.
Giacomini D; Páez-Pereda M; Theodoropoulou M; Labeur M; Refojo D; Gerez J; Chervin A; Berner S; Losa M; Buchfelder M; Renner U; Stalla GK; Arzt E
Endocrinology; 2006 Jan; 147(1):247-56. PubMed ID: 16195406
[TBL] [Abstract][Full Text] [Related]
2. Inhibitory effects of SOM230 on adrenocorticotropic hormone production and corticotroph tumor cell proliferation in vitro and in vivo.
Murasawa S; Kageyama K; Sugiyama A; Ishigame N; Niioka K; Suda T; Daimon M
Mol Cell Endocrinol; 2014 Aug; 394(1-2):37-46. PubMed ID: 25011056
[TBL] [Abstract][Full Text] [Related]
3. Pituitary tumors: cell type-specific roles for BMP-4.
Labeur M; Páez-Pereda M; Haedo M; Arzt E; Stalla GK
Mol Cell Endocrinol; 2010 Sep; 326(1-2):85-8. PubMed ID: 20398728
[TBL] [Abstract][Full Text] [Related]
4. [New mechanisms involved in the pathogenesis of pituitary adenomas].
Giacomini D; Páez-Pereda M; Refojo D; Carbia Nagashima A; Chervin A; Goldberg V; Arzt E
Medicina (B Aires); 2003; 63(2):147-50. PubMed ID: 12793085
[TBL] [Abstract][Full Text] [Related]
5. Involvement of bone morphogenetic protein 4 (BMP-4) in pituitary prolactinoma pathogenesis through a Smad/estrogen receptor crosstalk.
Paez-Pereda M; Giacomini D; Refojo D; Nagashima AC; Hopfner U; Grubler Y; Chervin A; Goldberg V; Goya R; Hentges ST; Low MJ; Holsboer F; Stalla GK; Arzt E
Proc Natl Acad Sci U S A; 2003 Feb; 100(3):1034-9. PubMed ID: 12552124
[TBL] [Abstract][Full Text] [Related]
6. Preincubation of pituitary tumor cells with the epidrugs zebularine and trichostatin A are permissive for retinoic acid-augmented expression of the BMP-4 and D2R genes.
Yacqub-Usman K; Duong CV; Clayton RN; Farrell WE
Endocrinology; 2013 May; 154(5):1711-21. PubMed ID: 23539512
[TBL] [Abstract][Full Text] [Related]
7. Bone morphogenetic protein-4 control of pituitary pathophysiology.
Giacomini D; Páez-Pereda M; Theodoropoulou M; Gerez J; Nagashima AC; Chervin A; Berner S; Labeur M; Refojo D; Renner U; Stalla GK; Arzt E
Front Horm Res; 2006; 35():22-31. PubMed ID: 16809920
[TBL] [Abstract][Full Text] [Related]
8. Retinoic acid as a novel medical therapy for Cushing's disease in dogs.
Castillo V; Giacomini D; Páez-Pereda M; Stalla J; Labeur M; Theodoropoulou M; Holsboer F; Grossman AB; Stalla GK; Arzt E
Endocrinology; 2006 Sep; 147(9):4438-44. PubMed ID: 16740975
[TBL] [Abstract][Full Text] [Related]
9. Retinoic acid prevents experimental Cushing syndrome.
Páez-Pereda M; Kovalovsky D; Hopfner U; Theodoropoulou M; Pagotto U; Uhl E; Losa M; Stalla J; Grübler Y; Missale C; Arzt E; Stalla GK
J Clin Invest; 2001 Oct; 108(8):1123-31. PubMed ID: 11602619
[TBL] [Abstract][Full Text] [Related]
10. Pituitary action of cytokines: focus on BMP-4 and gp130 family.
Giacomini D; Acuña M; Gerez J; Nagashima AC; Silberstein S; Páez-Pereda M; Labeur M; Theodoropoulou M; Renner U; Stalla GK; Arzt E
Neuroendocrinology; 2007; 85(2):94-100. PubMed ID: 17337883
[TBL] [Abstract][Full Text] [Related]
11. Low expression of the cell cycle inhibitor p27Kip1 in normal corticotroph cells, corticotroph tumors, and malignant pituitary tumors.
Lidhar K; Korbonits M; Jordan S; Khalimova Z; Kaltsas G; Lu X; Clayton RN; Jenkins PJ; Monson JP; Besser GM; Lowe DG; Grossman AB
J Clin Endocrinol Metab; 1999 Oct; 84(10):3823-30. PubMed ID: 10523037
[TBL] [Abstract][Full Text] [Related]
12. Crosstalk of BMP-4 and RA signaling pathways on Pomc gene regulation in corticotrophs.
Nieto L; Fuertes M; Rosmino J; Senin S; Arzt E
J Mol Endocrinol; 2019 Oct; 63(3):161-174. PubMed ID: 31394504
[TBL] [Abstract][Full Text] [Related]
13. Bone morphogenetic protein 4 and bone morphogenetic protein receptor expression in the pituitary gland of adult dogs in healthy condition and with ACTH-secreting pituitary adenoma.
Sato A; Ochi H; Harada Y; Yogo T; Kanno N; Hara Y
Domest Anim Endocrinol; 2017 Jan; 58():126-133. PubMed ID: 26542941
[TBL] [Abstract][Full Text] [Related]
14. Bone morphogenetic protein and retinoic acid-inducible neural specific protein-3 is expressed in gonadotrope cell pituitary adenomas and induces proliferation, migration, and invasion.
Shorts-Cary L; Xu M; Ertel J; Kleinschmidt-Demasters BK; Lillehei K; Matsuoka I; Nielsen-Preiss S; Wierman ME
Endocrinology; 2007 Mar; 148(3):967-75. PubMed ID: 17138656
[TBL] [Abstract][Full Text] [Related]
15. Biochemical assessment of Cushing's disease in patients with corticotroph macroadenomas.
Katznelson L; Bogan JS; Trob JR; Schoenfeld DA; Hedley-Whyte ET; Hsu DW; Zervas NT; Swearingen B; Sleeper M; Klibanski A
J Clin Endocrinol Metab; 1998 May; 83(5):1619-23. PubMed ID: 9589666
[TBL] [Abstract][Full Text] [Related]
16. Activation of the dopamine receptor type-2 (DRD2) promoter by 9-cis retinoic acid in a cellular model of Cushing's disease mediates the inhibition of cell proliferation and ACTH secretion without a complete corticotroph-to-melanotroph transdifferentiation.
Occhi G; Regazzo D; Albiger NM; Ceccato F; Ferasin S; Scanarini M; Denaro L; Cosma C; Plebani M; Cassarino MF; Mantovani G; Stalla GK; Pecori Giraldi F; Paez-Pareda M; Scaroni C
Endocrinology; 2014 Sep; 155(9):3538-49. PubMed ID: 24926820
[TBL] [Abstract][Full Text] [Related]
17. Molecular pathology shows p16 methylation in nonadenomatous pituitaries from patients with Cushing's disease.
Simpson DJ; McNicol AM; Murray DC; Bahar A; Turner HE; Wass JA; Esiri MM; Clayton RN; Farrell WE
Clin Cancer Res; 2004 Mar; 10(5):1780-8. PubMed ID: 15014032
[TBL] [Abstract][Full Text] [Related]
18. Effects of bone morphogenetic protein (BMP) on adrenocorticotropin production by pituitary corticotrope cells: involvement of up-regulation of BMP receptor signaling by somatostatin analogs.
Tsukamoto N; Otsuka F; Miyoshi T; Yamanaka R; Inagaki K; Yamashita M; Otani H; Takeda M; Suzuki J; Ogura T; Iwasaki Y; Makino H
Endocrinology; 2010 Mar; 151(3):1129-41. PubMed ID: 20056821
[TBL] [Abstract][Full Text] [Related]
19. Bone morphogenetic protein-2 stimulates angiogenesis in developing tumors.
Langenfeld EM; Langenfeld J
Mol Cancer Res; 2004 Mar; 2(3):141-9. PubMed ID: 15037653
[TBL] [Abstract][Full Text] [Related]
20. Identification of adrenocorticotropin receptor messenger ribonucleic acid in the human pituitary and its loss of expression in pituitary adenomas.
Morris DG; Kola B; Borboli N; Kaltsas GA; Gueorguiev M; McNicol AM; Ferrier R; Jones TH; Baldeweg S; Powell M; Czirják S; Hanzély Z; Johansson JO; Korbonits M; Grossman AB
J Clin Endocrinol Metab; 2003 Dec; 88(12):6080-7. PubMed ID: 14671214
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
